Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Most patients manage side effects successfully with supportive strategies and continue progressing toward their weight-loss goals
GLP-1 Therapies: Breakthroughs vs Breakdowns Skye Bioscience Chief Medical Officer, Puneet Arora, MD, discusses incretin drug hunger suppression, fat reduction and other benefits, and reviews complementary treatments to best address patients diverse needs
Wegovy works on the GLP-1 receptor only
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for several indications: type 2 diabetes management (under the brand names Ozempic and Rybelsus), chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related comorbidity (under the brand name Wegovy), and in adolescents aged 12 years and older with obesity
This increase has caused some patients who need semaglutide for disease management to have difficulty obtaining the drug
US$ 22.52
US$ 27.72
US$ 20.83
US$ 28.12
US$ 20.49
US$ 28.89
US$ 22.86
US$ 24.91
US$ 29.25
US$ 20.43
US$ 21.91
